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ARTICLE
HSP90 inhibitors stimulate DNAJB4 protein
expression through a mechanism involving
N6-methyladenosine
Weili Miao1, Lin Li1, Yonghui Zhao2,3, Xiaoxia Dai1, Xuemei Chen 2 & Yinsheng Wang1
Small-molecule inhibitors for the 90-kDa heat shock protein (HSP90) have been extensively
exploited in preclinical studies for the therapeutic interventions of human diseases accom-
panied with proteotoxic stress. By using an unbiased quantitative proteomic method, we
uncover that treatment with three HSP90 inhibitors results in elevated expression of a large
number of heat shock proteins. We also demonstrate that the HSP90 inhibitor-mediated
increase in expression of DNAJB4 protein occurs partly through an epitranscriptomic
mechanism, and is substantially modulated by the writer, eraser, and reader proteins of N6-
methyladenosine (m6A). Furthermore, exposure to ganetespib leads to elevated modification
levels at m6A motif sites in the 5′-UTR of DNAJB4 mRNA, and the methylation at adenosine
114 site in the 5′-UTR promotes the translation of the reporter gene mRNA. This m6A-
mediated mechanism is also at play upon heat shock treatment. Cumulatively, we unveil that
HSP90 inhibitors stimulate the translation of DNAJB4 through an epitranscriptomic
mechanism.
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RNA is known to harbor more than 100 types of covalentmodifications1, and the biological functions for most ofthese modifications remain poorly understood. Recent
studies documented the widespread occurrence of N6-methy-
ladenosine (m6A) in mRNA and the discovery of cellular
proteins that are involved in the deposition2–4, recognition5–7,
and removal8–10 of this modified nucleoside in mRNA. Thus,
reversible methylations in mRNA may constitute a very
important mechanism of gene regulation through modulating
the stability and translation efficiency of mRNA6,7,11. In addi-
tion, this mechanism may also assume important roles in stress
response12,13.
Heat shock response is among the best studied cellular stress
response pathways, where heat shock proteins enable homeostasis
of the proteome by preventing the aggregation and maintaining
the native structures of proteins in cells14. In this vein, the 90-kDa
heat shock protein (HSP90) is involved in assisting the folding of
a large number of so-called client proteins15. Moreover, small-
molecule inhibitors of HSP90 have been exploited in preclinical
stage for treating various human diseases16. It, however, remains
largely unexplored how treatment with these inhibitors modulates
the heat shock proteome in human cells.
In the present study, we uncover that treatment of human cells
with HSP90 inhibitors leads to substantial reprogramming of the
heat shock proteome, where pronounced increases in expression
are observed for DNAJB4 and HSPA1. We also find that
the elevated expression of DNAJB4 occurs, in part, through an
m6A-mediated epitranscriptomic mechanism, and a similar
mechanism is at play during heat shock response.
Results
HSP90 inhibitors stimulate the expression of HSPs. By
employing a recently developed targeted quantitative proteomic
method (Supplementary Fig. 1)17, we examined the alterations in
expression levels of heat shock proteins in response to treatment
with three small-molecule inhibitors of HSP90. These include
ganetespib and AT13387 (a.k.a. onalespib) of the resorcinol
chemotype, and 17-(dimethylaminoethylamino)-17-demethox-
ygeldanamycin (a.k.a. alvespimycin) of the ansamycin chemotype16.
All three inhibitors interact with the ATP-binding pocket located in
the N-terminal domain of HSP9016. Strikingly, our results showed
that a number of heat shock proteins, particularly HSPA1 and
DNAJB4, which belong to the HSP70 and HSP40 subfamilies,
respectively, displayed markedly elevated expression in M14 mela-
noma cells upon treatment with the three HSP90 inhibitors (Fig. 1a,
b, Supplementary Fig. 2, Supplementary Data 1).
We confirmed the altered expressions of several heat shock
proteins, namely HSP90, HSP70, DNAJB4, and HSPB1, in M14
cells by western blot analysis (Fig. 1c, d). The augmented
expression of HSP70 and DNAJB4 proteins was also observed in
HeLa and HEK293T cells upon a 24-h treatment with ganetespib,
though the magnitudes of increase were not as pronounced as
what we observed for M14 cells (Supplementary Fig. 3). It is
worth noting that the targeted proteomic method, which
quantifies proteins on the basis of specific peptides, allows for
the independent assessments of different isoforms of HSP90
(HSP90AA1 and HSP90AB1, a.k.a. HSP90α and HSP90β) and
HSP70 (HSPA1, HSPA2, HSPA7 and HSPA8, a.k.a. HSP70–1,
HSP70–2, HSP70B and HSC70, respectively) (Fig. 1b, d,
Supplementary Data 1). The commercially available antibodies
employed in our western blot analysis, however, recognize
multiple isoforms of HSP90 or HSP70. Thus, the magnitudes of
changes in expression of some heat shock proteins measured by
western blot analysis were not as large as those determined from
LC-MS/MS analysis.
Our quantitative proteomic data revealed a ~30-fold increase in
expression level of DNAJB4 after a 24-h treatment with ganetespib
(Supplementary Fig. 2); the mRNA level of this gene, however,
only exhibited a 6-fold elevation (Supplementary Fig. 4a). This
result suggests that ganetespib stimulates the expression of
DNAJB4 protein partly through a post-transcriptional mechan-
ism. This conclusion is further substantiated by the result obtained
from polysome fractionation followed by RT-qPCR analysis,
which showed augmented occupancy of DNAJB4 mRNA in the
polysome fraction after ganetespib treatment (Fig. 2a, Supple-
mentary Fig. 4b, c). In addition, absorbance at 254 nm for the
polysome fraction was increased at 6 h following ganetespib
treatment, though it returned to pretreatment levels at 24-h
following ganetespib treatment (Fig. 2b).
The elevated distribution of mRNA in the polysome fraction at
6-h following ganetespib treatment may be ascribed to elevated
protein synthesis, which we validated for a number of heat shock
proteins using a pulse-chase experiment (Supplementary Fig. 5).
In particular, the results from this experiment revealed augmen-
ted syntheses of many heat shock proteins in M14 cells after a 6-h
treatment with ganetespib (Supplementary Fig. 6, Supplementary
Data 2). The increases in newly synthesized heat shock proteins
in M14 cells upon ganetespib treatment are correlated with the
elevations in their overall levels of expression (Fig. 2c).
Our proteomic data also showed that the expression levels of
three other heat shock proteins (HSPA1, HSPB1, and HSPH1)
were upregulated by 26-, 2.5- and 3.6-fold at 24 h following
ganetespib exposure (Supplementary Data 1). Meanwhile, the
mRNA expression levels of the HSPA1, HSPB1, and HSPH1 genes
were increased by 50-, 5- and 5-fold at the same time point
(Supplementary Fig. 4a), suggesting that the HSP90 inhibitor-
elicited elevation in expression levels of these three heat shock
proteins occurs mainly through transcriptional regulation.
Increased DNAJB4 expression involves an m6A-based
mechanism. Recent studies showed that, in response to heat
shock stress, cells overexpress HSP70 protein through a
mechanism involving cap-independent translation enabled by
m6A in the 5′-untranslated region (UTR) of the mRNA of HSP70
gene12,13,18. Recent m6A sequencing studies with the use of
methylated RNA immunoprecipitation (MeRIP) method revealed
the presence of m6A peaks in multiple regions of DNAJB4 mRNA
isolated from mouse embryonic fibroblast cells and HEK293T
human embryonic kidney epithelial cells (Supplementary Fig. 7)
12,19. In this context, it is worth noting that a previous residue-
specific m6A mapping study, with the use of the m6A individual-
nucleotide-resolution cross-linking and immunoprecipitation
(miCLIP) method, only revealed two methylation sites in
DNAJB4 mRNA from HEK293T cells, which are situated in the
second exon and the 3′-UTR, respectively;20 the failure to detect
m6A in the 5′-UTR of DNAJB4 mRNA is perhaps attributed to
inadequate sensitivity of the miCLIP method. Furthermore, heat
shock could result in a substantial increase in the level of m6A in
the 5′-UTR of DNAJB4 mRNA in MEF cells (Supplementary
Fig. 7a) and a nearly 4-fold elevation in the ribosomal occupancy
of DNAJB4 mRNA, as revealed by m6A-seq and Ribo-seq
analyses, respectively12. Therefore, we asked whether a similar
mechanism contributes to the HSP90 inhibitor-induced aug-
mentation in DNAJB4 protein.
Our m6A RNA immunoprecipitation (RIP) together with RT-
qPCR result revealed an increased level of m6A in DNAJB4
mRNA after a 6-h treatment with ganetespib (Fig. 2d). We also
monitored the expression levels of DNAJB4, HSP70, ALKBH5,
FTO, METTL3, and YTHDF3 proteins in M14 cells at different
time intervals following treatment with 100 nM ganetespib. Our
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results revealed a marked increase in the levels of DNAJB4 and
HSP70, which paralleled the temporal profile of YTHDF3, though
no substantial increase was observed for the expression level of
ALKBH5, FTO, or METTL3 (Fig. 3).
We next asked how the ganetespib-stimulated increase in
DNAJB4 protein level is modulated by the reader, writer and
eraser proteins of m6A. We found that ectopic overexpression of
ALKBH5 and, to a lesser degree, FTO, significantly attenuated the
ganetespib-induced progressive increase in expression levels of
DNAJB4 protein (Fig. 4a, b). In this respect, FTO was previously
shown to demethylate both N6,2′-O-dimethyladenosine (m6Am)
in the mRNA cap structure10 and internal m6A21, and ALKBH5
was found to demethylate internal m6A in mRNA9. The reciprocal
experiment showed that small interfering RNA (siRNA)-mediated
knockdown of ALKBH5 further augmented the ganetespib-
induced elevation of DNAJB4 protein (Supplementary Fig. 8).
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Fig. 1 HSP90 inhibitors induced changes of heat shock proteome. a A heat map showing the alterations in expression levels of heat shock proteins in M14
cells upon a 24-h treatment with 100 nM of ganetespib, AT13387, or 17-DMAG. The data represent the mean of results obtained from two forward and
two reverse SILAC labeling experiments (Supplementary Data 1). b Representative PRM traces for monitoring the relative expression levels of several heat
shock proteins with or without HSP90 inhibitor treatment. c Western blot for validating the expression levels of select heat shock proteins after treatment
with the three HSP90 inhibitors. d Quantification data for the differences in expression levels of heat shock proteins in M14 cells with or without HSP90
inhibitor treatment, as obtained from western blot. The quantification data represent the mean ± S.D. of results from three independent experiments.
Source data are provided as a Source Data file
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On the other hand, siRNA-mediated depletion ofMETTL3, which
encodes the catalytic component of the major m6A methyltrans-
ferase complex2–4, abolished the ganetespib-induced elevated
expression of DNAJB4 (Fig. 4c, d). Likewise, CRISPR-Cas9-
mediated individual ablation of the three YTH domain-containing
proteins (i.e., YTHDF1, YTHDF2, and YTHDF3), which are
reader proteins for m6A5–7, also led to marked attenuation in the
ganetespib-induced increase in expression of DNAJB4 protein
(Fig. 5a, b and Supplementary Fig. 9). Furthermore, ectopic
reconstitution of YTHDF3 in the YTHDF3-knockout cells rescued
the elevated expression of DNAJB4 protein following ganetespib
treatment (Fig. 5c, d).
We also assessed the perturbations of the heat shock proteome
induced by ALKBH5 overexpression using the aforementioned
targeted proteomic method. It turned out that overexpression of
ALKBH5 in M14 cells only led to substantially decreased
expression of DNAJB4, DNAJB12, and HSP47 (Supplementary
Fig. 10a, Supplementary Data 3). Consistent with the quantitative
proteomic data, western blot results revealed that ALKBH5
overexpression did not exert any apparent effect on the
expression of HSPB1 protein (Supplementary Fig. 10b, c). These
results underscore that ALKBH5 modulates only a small subset of
heat shock proteins. In contrast to the observations made for
DNAJB4, DNAJB12, and HSP47, the expression level of HSPA14
protein exhibits a marked increase upon overexpression of
ALKBH5. An m6A site was previously identified in the last,
non-coding exon in HSPA14 mRNA20; however, the function of
this modification remains unclear. Further studies are needed to
determine whether the modification level at this m6A site is
modulated by ALKBH5 and how it affects HSPA14 translation.
We further explored the HSP90 inhibitor-elicited increase in
DNAJB4 protein synthesis by monitoring the m6A demethylase
activity in M14 cells with or without a 6-hr treatment with 100
nM ganetespib. Our results showed that the m6A demethylase
activity in the lysate of M14 cells was decreased to ~60% of the
level observed in DMSO-treated cells at 6 hr following ganetespib
treatment (Fig. 6a). This result suggests that exposure to
ganetespib and the ensuing proteotoxic stress may compromise
the activity of m6A demethylase(s) (e.g., ALKBH5).
m6A modification at A114 promotes the translation of
DNAJB4. Viewing that m6A modification in the 5′-UTR was
shown to promote cap-independent translation18, we next asked
whether the m6A levels in the 5′-UTR of DNAJB4 mRNA were
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Fig. 2 Ganetespib induced increased translation of DNAJB4. a RT-qPCR results show that the mRNA level of DNAJB4 exhibited a progressive increase in
the polysome fraction following ganetespib treatment in M14 cells. Data were normalized to the mRNA level of HPRT1 gene. b Traces for fractionation of
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normalized to the mRNA level of HPRT1 gene. The quantification data represent the mean ± S.D. of results from three independent experiments. The p-
values referred to the comparison between 0 h and the indicated time points following HSP90 inhibitor treatment and were calculated based on unpaired,
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elevated upon ganetespib treatment, and if the elevation of m6A
promotes the translation of DNAJB4. To measure the m6A level
at specific sites, we employed a recently reported single-base
elongation- and ligation-based qPCR amplification method
(SELECT)22. The method involves the use of two DNA probes
(Up and Down Probes) that are complementary to the mRNA
while leaving a single nucleotide gap at the putative m6A site. The
single-nucleotide extension of the Up Probe by Bst DNA poly-
merase and ligation of the resulting nick between the Up and
Down Probes by DNA ligase are both selectively hindered by the
presence of the m6A modification in the mRNA template. Hence,
quantitative PCR analysis of the resulting ligation product allows
for quantification of the extent of m6A modification at the site of
interest. By using this method, we monitored a total of seven
adenosine sites in the 5′-UTR of DNAJB4 mRNA (Fig. 6b, Sup-
plementary Fig. 11). These included the adenosines at all four
m6A motif sites (AAC or GAC)20 and three adenosines at U/CAA
sites (as negative controls) in the 5′-UTR (Fig. 6b). Our results
from the SELECT assay revealed that the template abundances
were increased by 4–5-fold at the three negative control sites after
ganetespib treatment (Fig. 6c), which is in line with the inhibitor-
induced increase DNAJB4 mRNA level (vide supra). Much lower
increases in template levels were, however, found at all four
adenosines at the m6A motif sites (i.e. adenosine residues 17, 41,
114, and 121, Fig. 6c), which reflect increased m6A levels at these
sites after ganetespib treatment. This result, together with the fact
that the four adenosines are situated at the m6A motif sites,
strongly suggested that ganetespib exposure led to increased m6A
levels at these sites in the 5′-UTR of DNAJB4 mRNA. In this
context, it is worth noting the inherent limitation of SELECT
assay, where the method does not provide definite evidence to
support that the modified nucleosides at these adenosine sites are
m6A.
After identifying the sites with elevated m6A levels, we next
examined the effects of methylation at the four m6A motif sites
on the translational efficiency of DNAJB4 by using a luciferase
reporter assay. Our results showed that only mutation of
adenosine 114, but not any other three adenosines at the m6A
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0.01≤ p < 0.05; **, 0.001≤ p < 0.01; ***, p < 0.001. Source data are provided as a Source Data file
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motif sites in the 5′-UTR, to a cytidine led to pronounced
diminution (by ~3-fold) in translation efficiency (Fig. 6d),
suggesting that the HSP90 inhibitor-elicited increase in m6A
level at adenosine 114 promoted the translation of
DNAJB4 mRNA.
Heat shock stress stimulates DNAJB4 protein expression. We
next examined whether a similar mechanism is at work in cells
under heat shock stress. It turned out that heat shock (by incu-
bating cells at 42 °C for 1 h) again induced a marked elevation in
the expression level of DNAJB4 protein, and this increase was
substantially diminished in cells upon siRNA-mediated depletion
of METTL3 (Fig. 7a, b), ectopic overexpression of ALKBH5
(Fig. 7c, d), or CRISPR-Cas9-mediated depletion of three YTH
domain-containing proteins (i.e., YTHDF1–3) (Fig. 7e, f). Hence,
heat shock induces the elevated expression of DNAJB4 through a
similar mechanism.
Discussion
Our quantitative proteomic method facilitated the assessment
about the reprogramming of the heat shock proteome in cultured
human cells in response to HSP90 inhibitor treatment en masse.
We found that treatment with three HSP90 inhibitors leads to
elevated expression of multiple heat shock proteins, with the most
pronounced increases being observed for HSPA1 and DNAJB4.
HSPA1 and DNAJB4 belong to the HSP70 and
HSP40 subfamilies of heat shock proteins, where HSP40 acts as a
co-chaperone for HSP70 by stimulating its ATPase activity and
enhancing its interaction with substrate proteins23. Our study
uncovers a regulatory mechanism of DNAJB4, where, in response
to proteotoxic stress induced by HSP90 inhibitor treatment, cells
stimulate the translation of DNAJB4 mRNA by upregulating m6A
modification in its 5′-UTR, which is modulated by the reader,
writer, and eraser proteins of m6A (Fig. 8). Mechanistically, we
found that treatment with HSP90 inhibitor led to diminished
m6A demethylase activity (Fig. 6a), which may arise from
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elevated proteotoxic stress elicited by compromised chaperone
activity of HSP90. To our knowledge, there is currently no reliable
method to measure independently the m6A methyltransferase
activity in live cells or cell lysates; thus, it remains unclear whe-
ther increased m6A methyltransferase activity also contributes to
HSP90 inhibitor-stimulated increase in m6A level in the 5′-UTR
of DNAJB4 mRNA. Our work, together with previous studies by
Zhou et al.12,13, showed that proteotoxic stress, arising from heat
shock or treatment with HSP90 inhibitors, results in elevated
translation of both HSP70 and its co-chaperone HSP40 via a
common m6A-mediated mechanism. Thus, our work demon-
strates that small-molecule HSP90 inhibitors can modulate gene
expression through epitranscriptomic mechanisms.
A growing body of the literature revealed the roles of m6A, and
its reader, writer, and eraser proteins in cancer biology24,25. The
results from the present study suggest that the modulation of m6A-
mediated epitranscriptomic mechanism by HSP90 inhibitors may
contribute, in part, to their anti-neoplastic effects. Additionally, a
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previous study showed that HSP70-HSP40 chaperones inhibit the
self-assembly of polyglutamine proteins into amyloid fibers26. In
addition, HSP90 inhibitors, including 17-AAG and 17-DMAG,
were found to be effective in ameliorating polyglutamine-mediated
motor neuron degeneration in a mouse model of spinal and bulbar
muscular atrophy (SBMA) through inducing the expression of
HSP70 and HSP40 proteins27,28. The mechanistic underpinnings
revealed from the present study suggest that the m6A-mediated
epitranscriptomic machinery may be harnessed for treating SBMA
and other neurological diseases emanating from protein aggrega-
tion and/or amyloid fiber formation.
Methods
Cell culture. M14 (National Cancer Institute), HeLa-S3 (ATCC, Catalog # CCL-
2.2), HEK293T (ATCC, Catalog # CRL-3216), and all CRISPR-engineered cells
were cultured in Dulbecco’s Modified Eagle Medium with 10% fetal bovine serum
(Invitrogen, Carlsbad, CA) and penicillin (100 IU/mL). The cells were maintained
at 37 °C in a humidified atmosphere containing 5% CO2. All cells were authenti-
cated by ATCC with short tandem repeats (STR) profiling and tested to ensure that
they were free of mycoplasma contamination with LookOut® Mycoplasma PCR
Detection Kit (Sigma). The cells were treated with 100 nM HSP90 inhibitors for the
indicated period of time, and, for heat shock treatment, the HEK293T cells were
incubated in a 42.0 °C water bath for 60 min. We also monitored, by using a
hemocytometer, the viability of M14 cells following HSP90 inhibitor treatment,
where we found that a 24-h treatment with 100 nM ganetespib, AT13387 and 17-
DMAG led to diminutions in the number of M14 cells by approximately 25%, 10%
and 35%, respectively (Supplementary Fig. 12). For SILAC labeling experiments,
M14 cells were cultured in SILAC DMEM medium containing [13C6,15N2]-lysine
and [13C6]-arginine for at least 10 days to promote complete incorporation of the
heavy isotope-labeled amino acids29. The complete heavy-isotope incorporation
was confirmed by LC-MS/MS analysis (Supplementary Fig. 13). It is worth noting
that heavy SILAC medium with a lower concentration of [13C6]-arginine (0.2 mM)
was employed to minimize the conversion of isotopically labeled arginine to pro-
line30. Under this condition, no appreciable conversion of labeled arginine to
proline was observed for proline-containing peptides.
Approximately 2 × 107 cells were harvested, washed with cold phosphate-
buffered saline (PBS) for three times, and lysed by incubating on ice for 30 min in
CelLytic M (Sigma) cell lysis reagent containing 1% protease inhibitor cocktail. The
cell lysates were centrifuged at 9000 × g at 4 °C for 30 min, and the resultant
supernatants collected.
Plasmid and siRNAs. The sequences for siMETTL3–1 and siMETTL3–2 were 5′-
CUGCAAGUAUGUUCACUAUGA-3′ and 5′-AGGAGCCAGCCAAGAAAU
CAA-3′, respectively2. The sequences for siALKBH5–1 and siALKBH5–2 were 5′-
ACAAGUACUUCUUCGGCGA-3′ and 5′-GCGCCGUCAUCAACGACUA-3′,
respectively31. siRNA was transfected using RNAiMAX (Invitrogen) following the
manufacturer’s protocol, where non-targeting siRNA (Dharmacon, D-
001210–02–20) was used as control. The pcDNA3.1-DYK plasmids for ectopic
expression of ALKBH5 and FTO were kindly provided by Prof. Chuan He (The
University of Chicago, Chicago, IL)32,33. The pRK7-YTHDF3 plasmid was con-
structed by amplifying the cDNA of YTHDF3 from pGEX-YTHDF3 provided by
Prof. Chuan He6 using the primers of 5′-GCTCTAGACCACCAATGTCAGAT
CCA-3′ and 5′-CGGGATCCTTGTTTGTTTCTATTTCTCTCCCTA-3′. The
plasmids were transfected into cells by using Lipofectamine 2000 (Life Technolo-
gies), following the manufacturer’s recommended procedures.
LC-PRM analysis. To assess the differential expression of heat shock proteins in M14
cells after HSP90 inhibitor treatment, we conducted two forward and two reverse
SILAC labeling experiments, where lysates of light-labeled, inhibitor-treated M14 cells
and heavy-labeled, mock (DMSO)-treated M14 cells were combined at 1:1 ratio (by
mass, based on Bradford assay) in the forward labeling experiment (Supplementary
Fig. 1a). The reverse labeling experiment was conducted in the opposite way. LC-MS/
MS analysis in the data-dependent acquisition mode on a Q Exactive Plus hybrid
quadrupole-Orbitrap mass spectrometer (Thermo Scientific, CA) showed that the
ratios of total ion intensities for the light- over heavy-labeled peptides fell in the range
of 0.91–1.09, where Maxquant, Version 1.5.2.834, was employed to identify the light
and heavy-labeled peptides and determine their intensity ratios (Supplementary
Table 1). This result suggests that the equi-mass mixing of light and heavy SILAC
lysates based on Bradford assay was reasonably accurate.
The proteins in the resulting light/heavy lysate mixtures were digested by
trypsin using the previously reported filter-aided sample preparation (FASP)
protocol35. Approximately 50 µg of cell lysates were washed with 8 M urea for
protein denaturation using a Microcon centrifugal filter with a molecular weight
cutoff of 30 kDa, and the urea buffer was then removed by centrifugation at
10,000 × g. The ensuing denatured proteins were reduced, alkylated, and digested
with modified MS-grade trypsin (Pierce) at an enzyme/substrate ratio of 1:100 in
50 mM NH4HCO3 (pH 8.5) at 37 °C overnight. The peptide mixture was
subsequently dried in a Speed-vac, desalted with OMIX C18 pipette tips (Agilent
Technologies). Around 500 ng peptides were analyzed by LC-MS/MS on a Q
Exactive Plus quadruple-Orbitrap mass spectrometer (Thermo Fisher Scientific) in
the PRM mode. The mass spectrometer was coupled with an EASY-nLC
1200 system (Thermo Scientific), and the samples were automatically loaded onto a
4-cm trapping column (150 µm i.d.) packed with ReproSil-Pur 120 C18-AQ resin
(5 µm in particle size and 120 Å in pore size, Dr. Maisch GmbH HPLC) at a flow
rate of 3 µL/min. The trapping column was coupled to a 20-cm fused silica
analytical column (PicoTip Emitter, New Objective, 75 µm i.d.) packed with
ReproSil-Pur 120 C18-AQ resin (3 µm in particle size and 120 Å in pore size, Dr.
Maisch GmbH HPLC). The peptides were then resolved using a 140-min linear
gradient of 9–38% acetonitrile in 0.1% formic acid and at a flow rate of 300 nL/min.
The spray voltage was 1.8 kV. Precursor ions were sequentially isolated, at a width
of 1.0m/z, and collisionally activated in the HCD cell at a collision energy of 29 to
yield MS/MS, which were acquired in the Orbitrap analyzer at a resolution of
17500 with an AGC target of 1 × 10517. Up to the five unique peptides with the
highest precursor ion intensities for each heat shock protein were selected in the
isolation list for LC-MS/MS or LC-PRM analysis, where the fragmentations of both
the light- and heavy-isotope labeled peptides were monitored.
Database search. Maxquant, Version 1.5.2.8, was used to analyze the LC-MS and
MS/MS data for protein identification34. The database we used for the search was
human IPI database, version 3.68, which contained 87,061 protein entries. The
maximum number of miss-cleavages for trypsin was two per peptide. Cysteine
carbamidomethylation was set as a fixed modification. Methionine oxidation and
serine, threonine and tyrosine phosphorylation were set as variable modifications.
The tolerances in mass accuracy were 20 ppm for MS and MS/MS acquired on the
Q Exactive Plus. The maximum false discovery rates (FDRs) were set at 0.01 at
both peptide and protein levels, and the minimum required peptide length was 6
amino acids.
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PRM data processing. All raw files were processed using Skyline (version 3.5)36
for the generation of extracted-ion chromatograms and peak integration. We
imposed a mass accuracy of within 20 ppm for fragment ions during the identi-
fication of peptides in the Skyline platform. The targeted peptides were manually
checked to ensure that the transitions for multiple fragment ions derived from light
and heavy forms of the same peptide exhibit the same elution time in the pre-
selected retention time window and display similar distribution as those in the MS/
MS acquired from shotgun proteomic analysis, with dot product value being
>0.737. The sum of peak areas from all transitions of light or heavy forms of
peptides was used for quantification.
Pulse-chase SILAC labeling and LC-PRM analysis. M14 cells were cultured in
SILAC light or heavy DMEM with 10% (v/v) dialyzed FBS, as described above.
Cells cultured in heavy and light SILAC media were rinsed with PBS, and switched
to light and heavy DMEM media, respectively. Immediately after the exchange of
culture media, the cells were treated with 100 nM ganetespib in DMSO or mocked
treated (with DMSO). After culturing for 6 h, the cells were harvested and lysates
prepared for LC-PRM analysis, as described above (Supplementary Fig. 5). The fold
difference in protein turnover was calculated by comparing the relative abundance
of the converted proteins with or without ganetespib treatment38. Peptides with
trypsin mis-cleavages were excluded from analysis.
CRISPR/Cas9-mediated genome editing of HEK293T cells. CRISPR targeting
was conducted following the previously reported protocols39, where the single
guide RNAs (sgRNAs) were designed as described (http://www.broadinstitute.org/
rnai/public/analysis-tools/sgrna-design)40,41. The guide sequences were
GTGGTGAGGTATGGAATCGGAGG for YTHDF1, TGAACCTTACTTGAGTC
CACAGG for YTHDF2, and ATAAAACACAACATGAATATTGG for YTHDF3,
where the last three letters indicate the PAM motif. Oligodeoxyribonucleotides
corresponding to target sequences were obtained from Integrated DNA Technol-
ogies and ligated into the hSpCas9 plasmid pX330 (Addgene). The constructed
plasmids were then transfected into HEK293T cells using Lipofectamine 2000
(Invitrogen) in a 6-well plate and individual cells were cultured for further analysis.
Genomic DNA was extracted from individual clonal cell lines, and specific DNA
regions surrounding the targeted sites were screened by PCR, followed by agarose
gel electrophoresis to assess the modification efficiency and by Sanger sequencing
to identify the deletion loci (Supplementary Fig. 9). A set of clones with both alleles
being cleaved by Cas9 were isolated, and the successful deletion of YTHDF1 and
YTHDF3 was further validated by western blot analysis (Fig. 5a).
Western blot. Cells were cultured in a 6-well plate and lysed at 60–80% confluency
following the above-described procedures. The concentrations of proteins in the
resulting lysates were determined using Bradford Assay (Bio-Rad). The whole-cell
lysate for each sample (10 μg) was denatured by boiling in Laemmli loading buffer
and subjected to SDS-PAGE separation. The proteins were subsequently trans-
ferred to a nitrocellulose membrane at 4 °C overnight. The resulting membrane was
blocked with PBS-T (PBS with 0.1% Tween 20) containing 5% milk (Bio-Rad) at 4 °
C for 6 h. The membrane was subsequently incubated with primary antibody at 4 °
C overnight and then with secondary antibody at room temperature for 1 h. After
thorough washing with PBS-T, the HRP signals were detected with Pierce ECL
Western Blotting Substrate (Thermo). The uncropped western blot images are
presented in the Source Data file.
Antibodies recognizing human ALKBH5 (Proteintech, 16837–1-AP, 1:50000
dilution), DNAJB4 (Santa Cruz Biotechnology, sc-100711, 1:4000 dilution), FTO
(Santa Cruz Biotechnology, sc-271713, 1:2000 dilution), HSP70 (Stressgen SPA-
810, 1:10,000 dilution), HSP90 (Santa Cruz Biotechnology, sc-13119, 1:10,000
dilution), HSPB1 (Santa Cruz Biotechnology, sc-13132, 1:10,000 dilution),
METTL3 (Proteintech, 15073–1-AP, 1:4000 dilution), YHTDF1 (Abcam, ab99080,
1:1000 dilution), YTHDF3 (Santa Cruz Biotechnology, sc-377119, 1:500 dilution),
and Flag epitope tag (Cell Signaling, 2368, 1:20,000 dilution) were employed as
primary antibodies. Horseradish peroxidase-conjugated anti-rabbit IgG, IRDye®
680LT Goat anti-Mouse IgG (1:10,000 dilution) were used as secondary antibodies.
Membranes were also probed with anti-actin antibody (Cell Signaling #4967,
1:10,000 dilution) to confirm equal protein loading.
Polysome profiling. Sucrose solutions were prepared in a polysome buffer (10 mM
HEPES, pH 7.4, 100 mM KCl, 5 mM MgCl2, 100 µg/ml cycloheximide and 2%
Triton X-100). Sucrose density gradients (15–60%, w/v) were freshly prepared in
SW 55 ultracentrifuge tubes (Backman) using a Gradient Master (BioComp
Instruments). M14 cells were pretreated with 100 µg/ml cycloheximide at 37 °C for
7 min followed by washing with ice-cold PBS containing 100 µg/ml cycloheximide.
The cells were then lysed in polysome lysis buffer. Cell debris was removed by
centrifugation at 18,000 × g for 10 min at 4 °C. OD254 was measured by using a
Nanodrop (Thermo) and the same amount of RNA was loaded onto sucrose
gradients followed by centrifugation at 237,000 × g for 90 min at 4 °C in an SW 55
rotor. The resulting sample was eluted at a flow rate of 0.5 ml/min through an
automated fractionation system (ISCO UA-5 UV detector, ISCO Inc.) that con-
tinuously monitored OD254 values. Aliquots of polysome fraction were used for
real-time PCR analysis.
m6A RNA immunoprecipitation (RIP). Eighty µg of total RNA isolated from M14
cells with or without ganetespib treatment was incubated with 4 μg anti-m6A
antibody (Millipore ABE572) in 1 × IP buffer (10 mM Tris-HCl, pH 7.4, 150 mM
NaCl, and 0.1% Igepal CA-630) at 4 °C for 2 h. The m6A-IP mixture was then
incubated with Protein A beads at 4 °C on a rotating wheel for an additional 2 h.
After washing for three times with the IP buffer, the bound RNA was eluted using a
50-µL elution buffer (6.7 mM N6-methyladenosine 5′-monophosphate in 1 × IP
buffer), followed by ethanol precipitation. The precipitated RNA was used for
reverse transcription and real-time PCR as described below.
Real-time PCR. M14 cells were seeded in 6-well plates at 50% confluence level.
Total RNA and polysome RNA were extracted from cells or polysome fraction
using TRI Reagent (Sigma). Approximately 3 μg RNA was reverse transcribed by
employing M-MLV reverse transcriptase (Promega) and an oligo(dT)18 primer.
After a 60-min incubation at 42 °C, the reverse transcriptase was deactivated by
heating at 75 °C for 5 min. Quantitative real-time PCR was performed using iQ
SYBR Green Supermix kit (Bio-Rad) on a Bio-Rad iCycler system (Bio-Rad), and
the running conditions were at 95 °C for 3 min and 45 cycles at 95 °C for 15 s, 55 °C
for 30 s, and 72 °C for 45 s. The comparative cycle threshold (Ct) method (ΔΔCt)
was used for the relative quantification of gene expression42, and the primers are
listed in Supplementary Table 2. The total mRNA level of each gene was nor-
malized to that of the internal control (GAPDH or HPRT1). The polysome occu-
pancy of DNAJB4 mRNA was normalized to that of internal control, HPRT16 or
GAPDH. The m6A level in the m6A RIP experiment was normalized to that of an
internal control, HPRT1.
In vitro m6A demethylase activity assay. The demethylase activity was measured
using an ELISA-based m6A demethylase assay kit (ab233489, Abcam, Cambridge,
MA). The M14 cells were cultured in a 6-well plate at 60–80% confluency and lysed
in a buffer containing 0.7% CHAPS, 50 mM HEPES (pH 7.4), 0.5 mM EDTA, 100
mM NaCl, and 1% protease inhibitor cocktail. The demethylase activity was
measured by monitoring absorbance at 450 nm using a Synergy H1 microplate
reader (Biotek, Winooski, VT) and calculated following the vendor’s recommended
procedures.
Single-base elongation and ligation-based qPCR amplification. Single-base
elongation and ligation-based qPCR amplification (SELECT) experiments were
performed following previously reported procedures22. Total RNA was mixed with
40 nM Up Primer, 40 nM Down Primer (Supplementary Table 3, Gene:
NM_007034.5) and 5 μM dNTP in a 17-μl 1 × CutSmart buffer. The RNA and
primers were annealed by incubating the mixture using a temperature gradient: 90
°C for 1 min, 80 °C for 1 min, 70 °C for 1 min, 60 °C for 1 min, 50 °C for 1 min, and
then 40 °C for 6 min. To the mixture were subsequently added a 3-μl solution
containing 0.01 U Bst 2.0 DNA polymerase, 0.5 U SplintR ligase and 10 nmol ATP
to make the final volume 20 μl. The final reaction mixture was incubated at 40 °C
for 20 min, denatured at 80 °C for 20 min and subsequently cooled to 4 °C. Real-
time quantitative PCR was subsequently performed using iQ SYBR Green Super-
mix kit (Bio-Rad) on a Bio-Rad iCycler system (Bio-Rad). The qPCR reaction (20
μl) was comprised of iQ SYBR Green Supermix, 200 nM qPCR forward primer,
200 nM qPCR reverse primer (Supplementary Table 3), 2 μl of the final reaction
mixture and water. qPCR was run at the following conditions: 95 °C, 5 min; (95 °C,
10 s; 60 °C, 35 s) × 40 cycles; 95 °C, 15 s. The comparative cycle threshold (Ct)
method (ΔΔCt) was used for the relative quantification of template abundance42.
Dual-luciferase reporter assay. The 5′-UTR of DNAJB4 gene was amplified by
from a cDNA library prepared from M14 cells using the primers of 5′-CATGCC
ATGGAGGATTGAATACAGAGAC-3′ and 5′-CATGCCATGGTTCGAATGCCT
TGAAAT-3′. cDNA was subcloned into NcoI-linearized pGL3-promoter vector
(Gene: NM_007034.5). The A17C, A41C, A114C, and A121C mutated pGL3 plas-
mids were constructed by amplifying from pGL3-DNAJB4–5′-UTR using the primers
listed in Supplementary Table 4. All plasmids were confirmed by Sanger sequencing.
pGL3 and pRL plasmids were co-transfected into M14 cells, and the cells were
treated with 100 nM ganetespib at 18 h later. After another 6 h, the cells were lysed.
The activities of firefly and Renilla luciferases were measured following the
vendor’s recommended procedures (Promega), where a Synergy H1 microplate
reader (Biotek, Winooski, VT) was used with a gain setting of 225, an integration
time of 10 s, and a delay time of 2000 ms.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Excel files containing the results of the LC-PRM analyses are provided as Supplementary
Data 1–3. All the raw files for both LC-MS/MS experiments and LC-PRM analyses of
heat shock proteins were deposited into PeptideAtlas with the identifier number of
PASS01226. The uncropped western blot image for Figs. 1c, 3a, b, c, 4a, c, 5a, c, 7a, c, e
and Supplementary Figs. 3a, b, 8a, 10b are provided in the Source Data file. The ratios
obtained from each individual replicate for Figs. 1d, 2a, 3a, b, c, 4b, d, 5b, d, 6c, 7b, d, f
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and Supplementary Figs. 3a, b, 4a, 8b, 10c are also provided in the Source Data file. All
other data are available from the corresponding author on reasonable request.
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